171 related articles for article (PubMed ID: 27764762)
1. Therapeutic outcomes of autologous CIK cells as a maintenance therapy in the treatment of lung cancer patients: A retrospective study.
Luo H; Gong L; Zhu B; Huang Y; Tang C; Yu S; Yang Z; Zhou X
Biomed Pharmacother; 2016 Dec; 84():987-993. PubMed ID: 27764762
[TBL] [Abstract][Full Text] [Related]
2. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
[TBL] [Abstract][Full Text] [Related]
3. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS).
Zhao Y; Qiao G; Wang X; Song Y; Zhou X; Jiang N; Zhou L; Huang H; Zhao J; Morse MA; Hobeika A; Ren J; Lyerly HK
Clin Transl Oncol; 2019 Jun; 21(6):721-728. PubMed ID: 30374838
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.
Wu C; Jiang J; Shi L; Xu N
Anticancer Res; 2008; 28(6B):3997-4002. PubMed ID: 19192663
[TBL] [Abstract][Full Text] [Related]
5. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.
Lin T; Song C; Chuo DY; Zhang H; Zhao J
Tumour Biol; 2016 Apr; 37(4):4367-72. PubMed ID: 26499782
[TBL] [Abstract][Full Text] [Related]
6. Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review.
Cai XR; Li X; Lin JX; Wang TT; Dong M; Chen ZH; Jia CC; Hong YF; Lin Q; Wu XY
Oncotarget; 2017 May; 8(19):31318-31328. PubMed ID: 28412743
[TBL] [Abstract][Full Text] [Related]
7. Maintenance therapy with autologous cytokine-induced killer cells in patients with advanced epithelial ovarian cancer after first-line treatment.
Liu J; Li H; Cao S; Zhang X; Yu J; Qi J; An X; Yu W; Ren X; Hao X
J Immunother; 2014; 37(2):115-22. PubMed ID: 24509174
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.
Xiao Z; Wang CQ; Zhou MH; Li NN; Liu SY; He YJ; Wang YZ; Feng JH; Yao XS; Chen L; Ma B; Yu S; Zeng XT; Li CW; Ding J
Int Immunopharmacol; 2018 Aug; 61():363-375. PubMed ID: 29945024
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy in combination with cytokine-induced killer cell transfusion: An effective therapeutic option for patients with extensive stage small cell lung cancer.
Huang J; Kan Q; Lan ; Zhao X; Zhang Z; Yang S; Li H; Wang L; Xu L; Cheng Z; Zhang Y
Int Immunopharmacol; 2017 May; 46():170-177. PubMed ID: 28292730
[TBL] [Abstract][Full Text] [Related]
10. Effect of maintenance therapy with dendritic cells: cytokine-induced killer cells in patients with advanced non-small cell lung cancer.
Shi SB; Ma TH; Li CH; Tang XY
Tumori; 2012; 98(3):314-9. PubMed ID: 22825506
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial.
Xu YC; Xu Q; Li JJ; Gu XF; Lin XL; Sun L; Lu HM; Tang L; Ma Y; Lu Z; Wang HX
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1315-23. PubMed ID: 26941189
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer.
Zhang L; Xu Y; Shen J; He F; Zhang D; Chen Z; Duan Y; Sun J
Radiat Oncol; 2016 Apr; 11():60. PubMed ID: 27097970
[TBL] [Abstract][Full Text] [Related]
13. Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies.
Niu Q; Wang W; Li Y; Qin S; Wang Y; Wan G; Guan J; Zhu W
Int Immunopharmacol; 2011 Apr; 11(4):449-56. PubMed ID: 21215350
[TBL] [Abstract][Full Text] [Related]
14. Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).
Gu Y; Lv H; Zhao J; Li Q; Mu G; Li J; Wuyang J; Lou G; Wang R; Zhang Y; Huang X
Int Immunopharmacol; 2017 Sep; 50():263-269. PubMed ID: 28711032
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of erlotinib plus dendritic cells and cytokine-induced killer cells in maintenance therapy of advanced non-small cell lung cancer.
Shi SB; Tang XY; Tian J; Chang CX; Li P; Qi JL
J Immunother; 2014 May; 37(4):250-5. PubMed ID: 24714359
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
[TBL] [Abstract][Full Text] [Related]
17. Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study.
Jiang N; Qiao G; Wang X; Morse MA; Gwin WR; Zhou L; Song Y; Zhao Y; Chen F; Zhou X; Huang L; Hobeika A; Yi X; Xia X; Guan Y; Song J; Ren J; Lyerly HK
Clin Cancer Res; 2017 Sep; 23(17):5066-5073. PubMed ID: 28611200
[No Abstract] [Full Text] [Related]
18. A clinical study evaluating dendritic and cytokine-induced killer cells combined with concurrent radiochemotherapy for stage IIIB non-small cell lung cancer.
Zhu XP; Xu YH; Zhou J; Pan XF
Genet Mol Res; 2015 Aug; 14(3):10228-35. PubMed ID: 26345959
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of dendritic cell-cytokine induced killer cells combined with concurrent chemoradiotherapy on locally advanced non-small cell lung cancer.
Tian L; Wang W; Yu B; Zhang G
J BUON; 2020; 25(5):2364-2370. PubMed ID: 33277857
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer.
Chen D; Sha H; Hu T; Dong S; Zhang J; Liu S; Cao H; Ma R; Wu Y; Jing C; Wang Z; Wu J; Feng J
Cell Death Dis; 2018 Mar; 9(3):366. PubMed ID: 29511158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]